Emmanuelle has more than 15 years’ experience Biotechnology Process Development and GMP production. Highly skilled in the field of cell culture applications, Emmanuelle joined Pall Biotech more than 10 years ago first as a Bioprocess Specialist (BPS) during 4 years. She then transitioned to the Bioreactor Applications team, where she was Principal Bioreactor Specialist until March 2021 when she joined the newly formed Gene Therapy business Unit as Strategic Technology Partnership Leader. Prior to Pall, Emmanuelle worked as Biotech Process Sciences Upstream Process development engineer at Merck Serono for 4 years. She received her Biotechnology Engineer diploma from the former Ecole Supérieure d’Ingénieurs de Luminy (now Polytech Marseille).